
Thoracic and Head & Neck medical oncologist @RutgersCancer. Husband and proud (step)grandfather. Maverick’s 🐾 dad. #clinicaltrials
New Jersey, USA
Joined July 2017
- Tweets1.4K
- Following660
- Followers690
- Likes6K
Missak Haigentz retweeted
Our Lung Cancer session has started with experts Dr. Salma Jabbour, Dr. Ashley McCormack, Dr. Missak Haigentz, Dr. Malini Patel, and Dr. Adam Lackey. #CancerNJ2026
@SalmaJabbour1 @DrHaigentz
Missak Haigentz retweeted
The @RutgersCancer @RWJBarnabas Annual Oncology Clinical Practice & Research Summit is underway! Physicians across our Oncology Service Line are together sharing the latest clinical and research advances. Thanks to @DrAEvens and @RCLanganMD for kicking off the event #CancerNJ2026
Missak Haigentz retweeted
Just published & so pleased to coauthor this key study showing FOLFOX with Atezo improves PFS for Deficient DNA Mismatch Repair Metastatic #Colorectalcancer in JCO ascopubs.org/doi/10.1200/JCO…. 👉New standard of care.👈Thanks to all! @SWOG @NRGonc @RutgersCancer @RWJBarnabas
And doctors too! Dr. Ioannis Kontopidis is a truly exceptional physician. Outstanding professionalism and bedside manner. Super thoughtful and talented surgical colleague. Very proud he’s on our multidisciplinary #lungcancer team @RWJBarnabas and @RutgersCancer! #lcsm
Our patients say it best at @RutgersCancer, #NJ’s only #National Cancer Institute – designated Comprehensive #Cancer Center!
#HealthCareHeroes
@RWJBarnabas
247
Missak Haigentz retweeted
🫁 ASCO 2026 lung cancer wrap-up: @DrHaigentz @RutgersCancer unpacks 3 abstracts with real clinical practice implications, from adjuvant targeted therapy to ADCs reshaping the immunotherapy backbone.
🔗 targetedonc.com/view/asco-20…
Missak Haigentz retweeted
Join leading experts from @RutgersCancer and @RWJBarnabas for the @OncLive State of the Science Summit: Lung Cancer, featuring insights on emerging treatments, clinical strategies, and real-world oncology approaches.
📅 June 17 | ⏰ 6:00–8:40 PM
📍 Chateau Grande Hotel, East Brunswick, NJ
Free to attend. Registration required: registration.onclive.com/sta…
Missak Haigentz retweeted
A wonderful and enlightening day at #ASCO26! Thank you to everyone who joined @RutgersCancer @RWJBarnabas at booth #11025 to learn about the exciting opportunities, comprehensive cancer care and groundbreaking research happening at New Jersey’s only NCI-designated Comprehensive Cancer Center.
Missak Haigentz retweeted
#ASCO26 has begun! Make sure to visit @RutgersCancer @RWJBarnabas at booth #11025 to learn about the amazing oncology care and research happening at NJ’s only NCI-designated Comprehensive Cancer Center!
Missak Haigentz retweeted
NOW OPEN @RutgersCancer: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch @CSHinrichsMD @RWJBarnabas cinj.org/clinical-trials/fin…
Missak Haigentz retweeted
Another memorable Texas Lung debate: T4N2 NSCLC: periop chemoIO approach vs. chemoRT→IO. Dr. @SalmaJabbour1 takes the trophy home. Both Drs. @BrendonStilesMD & Jabbour made a strong case and agreed that multi-D discussion & shared decision-making with patients remain key.
Missak Haigentz retweeted
Evidence shows T-cell therapies can deliver durable, potentially curative responses in #HPV-related cancers. Listen to @CSHinrichsMD as he details decade-long remission with TIL therapy and success with E7 targeted TCR-T cells: bit.ly/49Wfyhs @RutgersCancer @RWJBarnabas
Missak Haigentz retweeted
NOW OPEN @RutgersCancer: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” @CSHinrichsMD #ClinicalTrial #CancerResearch @RWJBarnabas cinj.org/clinical-trials/fin…
NCT05358548 is a parallel phase II trial testing novel, 6 WEEK SCHEDULES OF CHEMO combined with pembrolizumab in patients with advanced #lungcancer & #headandneckcancer. Open to enrollment @RutgersCancer and @RWJBarnabas partners.
#lcsm #hncsm
clinicaltrials.gov/study/NCT…
NOW OPEN @RutgersCancer: “Alternating Treatment Plans for Patients with Advanced Thoracic/HN Cancers (ATATcH).” @DrHaigentz #ClinicalTrial #CancerResearch @RWJBarnabas cinj.org/clinical-trials/fin…
135
Missak Haigentz retweeted
Saturday
Morning
Live from New York!
Make sure not to miss the 20th (!!!) big birthday bash of NY Lung- complete with amazing faculty and talks from “ABCs to ADCs” to “Bad Boys of Lung Cancer”along with challenging cases, tumor boards (note plural!), special NP/PA session etc covering all your thoracic needs!
Add to this the usual (mostly) friendly banter, a beautiful Fall weekend in NYC and the key question u should ask yourself- “how could i miss this?”
Then register asap below:
registration.gotoper.com/nyl…
(Free if using last name of favorite faculty… eg Halmos?😉)
@gotoPER @ChaftJamie
Missak Haigentz retweeted
NOW OPEN @RutgersCancer: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” @CSHinrichsMD #ClinicalTrial #CancerResearch @RWJBarnabas cinj.org/clinical-trials/fin…
Missak Haigentz retweeted
Today is World Lung Cancer Day. 🌎
Lung cancer is the leading cause of cancer death among both men and women in the United States.
🫁 Learn more about lung cancer with @RutgersCancer @RWJBarnabas expert Dr. Ioannis Kontopidis.
Missak Haigentz retweeted
Libutti (@slibutti, @RutgersCancer): "We need to ride out what I’ve heard referred to as a tempest and keep reassuring our faculty that we’re going to get through this together.”
cancerletter.com/podcastc/20…
Missak Haigentz retweeted
NOW OPEN @RutgersCancer: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” @CSHinrichsMD #ClinicalTrial #CancerResearch @RWJBarnabas cinj.org/clinical-trials/fin…
































